Drug Trial Radar · NCT05615220
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Last checked: Nov 19, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
216
Actual
Start
Jan 31, 2023
Primary completion
Jan 13, 2025
Study completion Feb 4, 2025
Sponsor
- Lead sponsor
- Emalex Biosciences Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD). The study includes an open-label period followed by a double-blind, placebo-controlled, randomized withdrawal period.
Conditions
- Tourette Disorder
Interventions
Ecopipam HydrochlorideDrug
Selective dopamine D1 and D5 receptor antagonist
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time From Randomization to Relapse in Participants Greater Than and Equal to (>=) 6 and Less Than (<) 18 Years During the Double-Blind R/WDTime frame: From randomization at Week 12 through the end of the double-blind R/WD period (up to Week 24)
Locations
95 sites in 12 countries. Site status is shown where the registry gives one.
Harmonex Neuroscience Research
Dothan, Alabama
Arkansas Children's Hospital
Little Rock, Arkansas
Advanced Research Center
Anaheim, California
CenExel CIT-IE
Bellflower, California
Cortica Site Network
Glendale, California
Amnova Clinical Research
Irvine, California
Cortica Site Network - San Rafael
San Rafael, California
Syrentis Clinical Research
Santa Ana, California
Yale School of Medicine
New Haven, Connecticut
University of Florida
Gainesville, Florida
NW FL Clinical Research Group, LLC
Gulf Breeze, Florida
Research in Miami Inc
Hialeah, Florida
Emcrown Clinical Research
Jensen Beach, Florida
University of Miami Miller School of Medicine
Miami, Florida
Florida International Research Center
Miami, Florida
Care Research Center
Miami, Florida
Medical Research Group of Central Florida
Orange City, Florida
APG Research LLC
Orlando, Florida
University of South Florida
St. Petersburg, Florida
Pediatric Epilepsy and Neurology Specialists
Tampa, Florida
Jedidiah Clinical Research
Tampa, Florida
Pediatric Neurology, PA
Winter Park, Florida
Advanced Discovery Research, LLC
Atlanta, Georgia
Rare Disease Research, LLC
Atlanta, Georgia
Atlanta Behavioral Research, LLC.
Atlanta, Georgia
Lurie Children Hospital of Chicago
Chicago, Illinois
1725 W. Harrison St., Suite 755
Chicago, Illinois
The University of Chicago Hospitals
Chicago, Illinois
Josephson-Wallack-Munshower Neurology
Indianapolis, Indiana
Massachusetts General Hospital
Boston, Massachusetts
Boston Children's Hospital
Boston, Massachusetts
Umass Chan Medical School
Worcester, Massachusetts
Michigan Clinical Research Institute PC
Ann Arbor, Michigan
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan
The Childrens Mercy Hospital
Kansas City, Missouri
Midwest Research Group
Saint Charles, Missouri
Washington University School of Medicine
St Louis, Missouri
Alivation Research
Lincoln, Nebraska
NYU Child Study Center
New York, New York
Mount Sinai School of Medicine
New York, New York
Showing 40 of 95 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.